European sales drive modest growth at polymer maker Victrex

FTSE 250-listed polymer manufacturer Victrex has posted modest growth results for the six month period ended March 31st underpinned by growth in its Europen sales.

FTSE 250-listed polymer manufacturer Victrex has posted modest growth results for the six month period ended March 31st underpinned by growth in its Europen sales.

The group, which comprises two divisions - Victrex Polymer Solutions, which focuses on transport, industrial and the electronics market, and Invibio Biomaterial Solution provides specialist solutions for medical device manufacturers - posted a 1.0% rise in its group profit over the period to £106.4m.

Earnings per share were up 41.7p, group gross margins were maintained at 67% and the interim dividend increased by 15%.

Volume in Europe of 767 tonnes was 8.0% ahead of the prior year, driven by growth in the non-implantable medical and transport markets, the group said.

In the US, sales volume of 388 tonnes was 4.0% below the prior year with weaker sales for the period in the oil and gas sector partially offset by increased sales into consumer electronics.

In Asia, sales volume of 237 tonnes was 10% down on the prior year which the group said was mainly due to a slowdown in sales into the semiconductor sector and the challenges faced by the Japanese market. Outside of Japan, sales volume was broadly in line with the prior year.

Anita Frew, Chairman of the group, said: "We are pleased to report that group revenue and earnings per share for the first half of our financial year are ahead of the same period for last year, despite the continued economic challenges faced by some of our end markets."

She added: "The group's strong gross margin has been maintained and we have continued to invest in resources to drive key growth programmes. Cash generation remains strong, funding the PEEK capacity expansion project, which is on track, and underpinning our progressive dividend policy, which is reflected in a 15% increase in the interim dividend."

MF

Recommended

Ensign Group: profiting from US private care
Trading

Ensign Group: profiting from US private care

Nursing and care-home specialist Ensign Group should thrive as Americans age. Matthew Partridge picks the best way to play it.
28 Sep 2021
How to profit from India’s high-tech recovery
Share tips

How to profit from India’s high-tech recovery

Professional investor David Cornell of the India Capital Growth Fund, selects three of his favourite Indian stocks to buy now.
27 Sep 2021
Share tips of the week – 24 September
Share tips

Share tips of the week – 24 September

MoneyWeek’s comprehensive guide to the best of this week’s share tips from the rest of the UK's financial pages.
24 Sep 2021
Three strong Asian stocks trading at bargain prices
Share tips

Three strong Asian stocks trading at bargain prices

Professional investor Nitin Bajaj of the Fidelity Asian Values investment trust picks three stocks that dominate their industries, earn good returns o…
20 Sep 2021

Most Popular

A nightmare 1970s scenario for investors is edging closer
Investment strategy

A nightmare 1970s scenario for investors is edging closer

Inflation need not be a worry unless it is driven by labour market shortages. Unfortunately, writes macroeconomist Philip Pilkington, that’s exactly w…
17 Sep 2021
What really causes inflation? Here’s what prices since 1970 tell us
Inflation

What really causes inflation? Here’s what prices since 1970 tell us

As UK inflation hits 3.2%, Dominic Frisby compares the cost of living 50 years ago with that of today, and explains how debt drives prices higher.
15 Sep 2021
The times may be changing, but don’t change how you invest
Small cap stocks

The times may be changing, but don’t change how you invest

We are living in strange times. But the basics of investing remain the same: buy fairly-priced stocks that can provide an income. And there are few be…
13 Sep 2021